23189-7421 The effect of neuroprotective 5-HT2-receptorantagonistic 4-fluoro-phenyl compounds is intensified synergistically by 5-HT1A-receptoragonistic aminonmethyl-chromans. The combination of 5-HT1A-receptoragonistic aminomethyl-chromans and 5-HT2-receptorantagonistic 4-fluoro-phenyl compounds is suitable for the treatment of cerebral ischaemias.
COMBINATION HAVING A NEUROPROTECTIVE EFFECT